LP
Laura Prendergast Stifel Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
13
Avg Return
Past Year
Past Year
55%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
91.7%
Neutral
8.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $24 |
27%
downside
| 2 | +41% |
0
%
| 9 Mar ‘26 3 months ago |
|
|
|
Buy
Initiated
| $48 |
386%
upside
| 1 | -30% |
0
%
| 11 Feb ‘26 4 months ago |
|
|
|
Buy
Initiated
| $23 |
198%
upside
| 1 | -15% |
0
%
| 11 Feb ‘26 4 months ago |
|
|
|
Buy
Maintained
| $170 |
6%
upside
| 2 | +61% |
0
%
| 22 Jan ‘26 4 months ago |
|
|
|
Buy
Initiated
| $12 |
192%
upside
| 1 | +16% |
0
%
| 4 Dec ‘25 6 months ago |
|
|
|
Buy
Maintained
| $135 |
9%
upside
| 2 | +5.7% |
0
%
| 17 Nov ‘25 7 months ago |
|
|
|
Buy
Reinstated
| $8 |
365%
upside
| 1 | -47% |
0
%
| 16 Oct ‘25 8 months ago |
|
|
|
Buy
Initiated
| $4 |
72%
downside
| 2 | +262% |
0
%
| 16 Oct ‘25 8 months ago |
|
|
|
Hold
Initiated
| $16 |
52%
downside
| 1 | – |
–
| 16 Oct ‘25 8 months ago |
|